Protein-encapsulated doxorubicin reduces cardiotoxicity in hiPSC-cardiomyocytes and cardiac spheroids while maintaining anticancer efficacy
Stem Cell Reports · 2023
DOI: 10.1016/j.stemcr.2023.08.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cell Reports, 2023. Verfasst von Madelyn Arzt und 14 weiteren Autor:innen. Beteiligte Einrichtung: Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA; Smidt Heart Institute, Cedars-Sinai Medical Ce…. Hauptthemen laut MEDLINE: Myocytes, Cardiac, Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Institutes of Health, US Department of Defense.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA; Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA; Department of Biomedical Sciences, Cedars-…
- Department of Surgery, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
- Department of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Center for Pharmacogenomics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
- Department of Chemistry and Biochemistry, University of Southern Mississippi, Hattiesburg, MS, USA.
- Division of Chemistry & Chemical Engineering, California Institute of Technology, Pasadena, CA, USA; Sunstate Biosciences LLC, Monrovia, CA, USA.
- Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Förderung
- NCI NIH HHS
- National Institutes of Health
- US Department of Defense
- California Institute for Regenerative Medicine
- NASA
- American Heart Association Inc
- Fashion Footwear Association of New York
- Margie and Robert E. Petersen Foundation
Zitieren
APA
Arzt, M., Gao, B., Mozneb, M., Pohlman, S., Cejas, R. B., Liu, Q., Huang, F., Yu, C., Zhang, Y., Fan, X., Jenkins, A., Giuliano, A. E., Burridge, P. W., Cui, X., & Sharma, A. (2023). Protein-encapsulated doxorubicin reduces cardiotoxicity in hiPSC-cardiomyocytes and cardiac spheroids while maintaining anticancer efficacy. Stem Cell Reports. https://doi.org/10.1016/j.stemcr.2023.08.005
Vancouver
Arzt M, Gao B, Mozneb M, Pohlman S, Cejas RB, Liu Q, et al. Protein-encapsulated doxorubicin reduces cardiotoxicity in hiPSC-cardiomyocytes and cardiac spheroids while maintaining anticancer efficacy. Stem Cell Reports. 2023. doi:10.1016/j.stemcr.2023.08.005
BibTeX
@article{Arzt2023,
author = {Arzt, Madelyn and Gao, Bowen and Mozneb, Maedeh and Pohlman, Stephany and Cejas, Romina B and Liu, Qizhi and Huang, Faqing and Yu, Changjun and Zhang, Yi and Fan, Xuemo and Jenkins, Amelia and Giuliano, Armando E and Burridge, Paul W and Cui, Xiaojiang and Sharma, Arun},
title = {Protein-encapsulated doxorubicin reduces cardiotoxicity in hiPSC-cardiomyocytes and cardiac spheroids while maintaining anticancer efficacy},
journal = {Stem Cell Reports},
year = {2023},
doi = {10.1016/j.stemcr.2023.08.005}
}
EUVIMED